Clinical Drug Investigation

Journal Metrics
(Based on the publications from the last 4 years)
(from 2020-11-01 to roughly 2024-11-01)
Number of papers416
H4-Index18
TQCC6
Average citations4.435
Median citations2
Impact Factor2.900 (based on Web of Science 2023)

(API-Link)

Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
Most cited by this journal
(Based on citations to the other journals in the most recent 30 papers in this journal, at least if metadata about citations were available; last updated 2023-11-16)
Impactful Papers
(Based on publications since 2023; last updated 2024-08-26)
Altmetric Attention Score: 212
Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence
Clinical Drug Investigation 2023-10-05
Altmetric Attention Score: 125
Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?
Clinical Drug Investigation 2023-07-30
Altmetric Attention Score: 14
Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care
Clinical Drug Investigation 2024-01-13
Altmetric Attention Score: 13
Lecanemab: More Questions Than Answers!
Clinical Drug Investigation 2023-12-15
Altmetric Attention Score: 12
Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors: Time for
Clinical Drug Investigation 2024-02-03
Ad
0.15593504905701